; (3) in paragraph (11) (as so redesignated), by adding at the end the following: (I) The activities necessary for exploration and implementation of the United States and European Union Mutual Recognition Agreement for Pharmaceutical Good Manufacturing Practice Inspections, and the United States and United Kingdom Mutual Recognition Agreement Sectoral Annex for Pharmaceutical Good Manufacturing Practices, and other mutual recognition agreements , with respect to generic new animal drug products subject to review, including implementation activities prior to and following product approval. ; and (4) by inserting after paragraph (11) (as so redesignated) the following: (12) Request to establish a generic investigational new animal drug file The term request to establish a generic investigational new animal drug file means the submission to the Secretary of a request to establish a generic investigational new animal drug file to contain investigational submissions for a generic new animal drug. . 203. Reauthorization; reporting requirements Section 742 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 379j–22 ) is amended— (1) in subsection (a), by striking 2018 and inserting 2023 ; (2) by striking 2019 each place it appears in subsections (a) and (b) and inserting 2024